InvestSMART

Cochlear Limited (ASX:COH)

ALERT: Price-sensitive ASX Announcement for COH
Current share price for COH : $135.480 -32.46 (-19.33%)+
Announcement
Release
22 Apr 2026 8:20AM
Price at Release
$167.940
Full Release
download
Summary
Cochlear Limited has issued a trading update and revised its FY26 earnings guidance downward due to softer than expected trading conditions in developed markets and heightened uncertainty in the Middle East. The company's second half sales growth is anticipated to be between 2-6% in constant currency. Contributing factors to the guidance reduction include potential provisions for receivables due to the Middle Eastern conflict, a decrease in gross margin, expenses from reshaping the cost base, and the impact of a stronger Australian dollar. Consequently, Cochlear's underlying net profit guidance for FY26 has been reduced to $290-330 million. Despite these challenges, the company remains confident in its growth strategy and plans to continue investing in the adult and seniors segment and new product developments.
Key Points
  • Trading conditions for cochlear implants in developed markets are softer than expected.
  • Heightened uncertainty to fourth quarter sales from the Middle East due to conflict.
  • Second half sales growth expected to be 2-6% in constant currency.
  • Cochlear reducing FY26 net profit guidance to $290-330 million.
  • Potential $10 million net profit impact from provisions for receivables due to Middle East conflict.
  • Gross margin expected to be impacted by around one percentage point due to lower demand.
  • Expenses from reshaping cost base could impact net profit by approximately $18-25 million.
  • Foreign exchange impact due to stronger Australian dollar estimated at $25 million after tax.
  • Cochlear remains confident in its growth strategy and market leadership.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.